Alternatively, in the presence of H3.3-G34 oncohistone mutations, along with TP53 and ATRX loss of function (LOF) and PDGFRA gain of function (GOF), H3.3-G34-mutant gliomas develop. The gene discussed is ATRX; the disease is central nervous system cancer.